Stephanie W. Bignon

Our Website Uses Cookies

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

PDF Binder
- Create PDF
- Add to Binder
Word Document Binder

Stephanie W. Bignon

Associate

Washington +1 202 662 5393 sbignon@cov.com Download V-card

View Less

Stephanie W. Bignon is a corporate associate in the firm’s Washington, DC office. Her practice focuses on advising public companies with respect to securities law matters, including, for example, capital markets transactions and securities disclosure and compliance issues.

Represented Eli Lilly and Company in a $1.0 billion registered offering of notes, consisting of $600.0 million of 1.950% notes due 2019 and $400.0 million of 4.650% notes due 2044.
Represented Salix Pharmaceuticals, Ltd. in its $750 million offering of 6.00% senior notes due 2021 in connection with its $2.6 billion acquisition of Santarus, Inc.
Represented the National Football League in connection with various league and stadium financings and ownership transactions, including its G-4 stadium funding program.
Assists Fortune 500 and other public companies in the preparation of periodic reports under the Securities Exchange Act of 1934 and on other securities law compliance matters, including under the Dodd-Frank Act.

Drafted corporate organizational and governing documents for a non-profit organization and advised on corporate governance issues.
Represented a client in connection with a petition by the probation office to revoke supervised release.

Senior External Reporting Analyst in the External Financial Reporting group at Delta Air Lines (2007-2008).
Assurance Associate (2005-2007) and Senior Assurance Associate (2007) at Grant Thornton LLP.

Covington Advises Salix in $2.6 Billion Acquisition of Santarus

WASHINGTON, DC, November 7, 2013 — Salix Pharmaceuticals, Ltd., and Santarus, Inc. announced today that the companies have entered into a merger agreement where Salix will acquire all of the outstanding stock of Santarus for $32 in cash per share, for a total value of approximately $2.6 billion. Covington & Burling LLP is advising Salix on both the acquisition ...

Covington Advises USTA in ESPN Broadcast Deal

WASHINGTON, DC, May 17, 2013 — The United States Tennis Association Incorporated and ESPN, Inc. announced a new 11-year broadcast deal Thursday that calls for telecasting the entire US Open exclusively on ESPN networks starting in 2015. Covington & Burling advised the USTA on the transaction. Under the agreement, ESPN will become the exclusive domestic ...

Our Website Uses Cookies

Representative Matters

Pro Bono

Previous Experience

News and Insights (Showing 4 of 4) (Showing 4 of 4)

Covington Advises Salix in $2.6 Billion Acquisition of Santarus

Covington Advises USTA in ESPN Broadcast Deal

Rule 10b5-1 Trading Plans: Avoiding the Heat

Giles v. California: Forfeiting Justice Instead of Confrontation Rights in the Court’s Most Recent Forfeiture by Wrongdoing Jurisprudence

Practices

Industries

Education

University of Maryland School of Law, J.D., 2011

Georgia Institute of Technology, B.S., 2005

Judicial Clerkship

Bar Admissions

Languages